A Clinically-Compatible Workflow for Computer-Aided Assessment of Brain Disease Activity in Multiple Sclerosis Patients

Over the last 10 years, the number of approved disease modifying drugs acting on the focal inflammatory process in Multiple Sclerosis (MS) has increased from 3 to 10. This wide choice offers the opportunity of a personalized medicine with the objective of no clinical and radiological activity for ea...

Full description

Bibliographic Details
Main Authors: Benoit Combès, Anne Kerbrat, Guillaume Pasquier, Olivier Commowick, Brandon Le Bon, Francesca Galassi, Philippe L'Hostis, Nora El Graoui, Raphael Chouteau, Emmanuel Cordonnier, Gilles Edan, Jean-Christophe Ferré
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.740248/full